Form D · Private Equity Fund
OrbiMed Private Investments IX, LP
New York, NY · CIK 0001920984
Offering snapshot reported Apr 28, 2023 · SEC filing
- Reported sold
- $1.85B Offering amount: $1.9B
- Investors reported
- 141 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 141
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2023 | Amendment | $1,849,550,000 | No comparison | 141 | SEC filing |
| Apr 28, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443751
The total amount sold includes capital committed by the General Partner.
Source: Form D, filed Apr 28, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ORBIMED PRIVATE INVESTMENTS IX, LP
Investment adviser: ORBIMED ADVISORS LLC
- Gross asset value
- $2.19B
- Beneficial owners
- 293
- ADV minimum commitment
- $1M
Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG LLP
PCAOB 185
Filing source
Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-2258697554
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David P. Bonita | Executive |
| Sven H. Borho | Executive |
| Carl L. Gordon | Executive |
| Geoffrey C. Hsu | Executive |
| W. Carter Neild | Executive |
| N/A Orbi Med Advisors Llc | Executive |
| N/A Orbi Med Capital Gp Ix Llc | Executive |
| Matthew S. Rizzo | Executive |
| C. Scotland Stevens | Executive |
| Peter A. Thompson | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022